Postgraduate Student; Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Haryana, India.
Internt, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Haryana, India.
J Assoc Physicians India. 2022 Jun;70(6):11-12. doi: 10.5005/japi-11001-0024.
Dengue fever is amongst the most cardinal arthropod-borne infection among humans. Around the world, an estimated 2.5 billion individuals are at peril of infection, of which approximately 975 million reside in urban areas of tropical and subtropical nations like Southeast Asia, the Pacific, and surprisingly Americas. Acute kidney injury (AKI) is so far not a well-studied dengue complication. The renal abnormalities, though not common, are AKI, proteinuria, glomerulonephritis, and hemolytic uraemic syndrome, which are considered complications of the disease. This study was designed to evaluate the prevalence of AKI in DF and find out the predictors of the development of AKI in patients with DI.
This one-year hospital-based cross-sectional study was performed in the Department of General Medicine, Maharishi Markandeshwar Institute of Medical Sciences and Research, Mullana, Ambala from March 2020 to April 2021. A total of 120 eligible patients with DI were enrolled. These patients were evaluated for AKI based on acute kidney injury network (AKIN) criteria.
The majority of the patients were males 57.5% and the male to female ratio was 1.35:1. Most of the patients were aged between 31 and 50 years (40.8%) and the mean age was 42.23 ± 16.28 years. The majority of the patients (72.5%) had DF, 13.3% of the patients had dengue fever with warning signs and 14.2% of the patients had severe dengue. The prevalence of AKI was 27.5% in patients with dengue fever. Other than AKI, Acute respiratory distress syndrome (ARDS) (11.7%), Multiple Organ Dysfunction Syndrome (MODS) (3.3%), and sepsis (0.8%) were the complications noted. The majority of the patients (83.3%) improved and were discharged and mortality was noted in 16.7% of the patients. Also, significant differences were noted in patients with and without AKI.
登革热是人类中最重要的节肢动物传播感染之一。在全球范围内,估计有 25 亿人面临感染的风险,其中约 9.75 亿人居住在东南亚、太平洋和令人惊讶的美洲等热带和亚热带国家的城市地区。急性肾损伤(AKI)目前并不是一个研究充分的登革热并发症。肾脏异常虽然不常见,但包括 AKI、蛋白尿、肾小球肾炎和溶血尿毒综合征,这些都被认为是该疾病的并发症。本研究旨在评估 DF 中 AKI 的患病率,并确定 DI 患者 AKI 发展的预测因素。
这是一项为期一年的基于医院的横断面研究,于 2020 年 3 月至 2021 年 4 月在马哈里希·马克丹德什瓦尔医学科学与研究学院内科进行。共纳入 120 名符合条件的 DI 患者。这些患者根据急性肾损伤网络(AKIN)标准评估 AKI。
大多数患者为男性(57.5%),男女比例为 1.35:1。大多数患者年龄在 31 至 50 岁之间(40.8%),平均年龄为 42.23 ± 16.28 岁。大多数患者(72.5%)患有 DF,13.3%的患者有警告症状的登革热,14.2%的患者患有重症登革热。登革热患者 AKI 的患病率为 27.5%。除 AKI 外,还观察到急性呼吸窘迫综合征(ARDS)(11.7%)、多器官功能障碍综合征(MODS)(3.3%)和脓毒症(0.8%)等并发症。大多数患者(83.3%)好转出院,死亡率为 16.7%。此外,有和没有 AKI 的患者之间存在显著差异。